InvestorsHub Logo
Followers 1
Posts 42
Boards Moderated 0
Alias Born 03/01/2014

Re: None

Sunday, 04/13/2014 8:08:22 PM

Sunday, April 13, 2014 8:08:22 PM

Post# of 3833
Galectin have a advantage right now I believe as many of the larger companies are more focused on hepatitis c , looks like that will be old news in the next few years and more companies will focus on reversing advanced fibrosis , cirhossis
Lets hope Galectin is for real and the next cohort results continue to impress
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News